AAAAAA

   
Results: 1-12 |
Results: 12

Authors: BACKONJA M BEYDOUN A EDWARDS KR SCHWARTZ SL FONSECA V HES M LAMOREAUX L GAROFALO E
Citation: M. Backonja et al., GABAPENTIN FOR THE SYMPTOMATIC TREATMENT OF PAINFUL NEUROPATHY IN PATIENTS WITH DIABETES-MELLITUS - A RANDOMIZED CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 280(21), 1998, pp. 1831-1836

Authors: EDWARDS KR HES MS LAMOREAUX LK GAROFALO EA KOTO EM
Citation: Kr. Edwards et al., GABAPENTIN (NEURONTIN(R)) FOR PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY(945-210), Neurology, 50(4), 1998, pp. 6011-6011

Authors: POTTER D EDWARDS KR
Citation: D. Potter et Kr. Edwards, POTENTIAL ROLE OF TOPIRAMATE IN RELIEF OF NEUROPATHIC PAIN, Neurology, 50(4), 1998, pp. 26005-26005

Authors: EDWARDS KR KAMIN M
Citation: Kr. Edwards et M. Kamin, THE BENEFICIAL EFFECT OF SLOWING THE INITIAL TITRATION RATE OF TOPIRAMATE, Neurology, 48(3), 1997, pp. 1042-1042

Authors: POTTER DL EDWARDS KR BROWN DS
Citation: Dl. Potter et al., AN OPEN-LABEL STUDY OF TACRINE FOR TREATMENT OF RESIDUAL COGNITIVE DEFECTS IN PATIENTS WITH TRAUMATIC BRAIN INJURY, Neurology, 48(3), 1997, pp. 1069-1069

Authors: CLEELAND CS NAKAMURA Y HOWLAND EW MORGAN NR EDWARDS KR BACKONJA M
Citation: Cs. Cleeland et al., EFFECTS OF ORAL MORPHINE ON COLD PRESSOR TOLERANCE TIME AND NEUROPSYCHOLOGICAL PERFORMANCE, Neuropsychopharmacology, 15(3), 1996, pp. 252-262

Authors: CLEELAND CS NAKAMURA Y MENDOZA TR EDWARDS KR DOUGLAS J SERLIN RC
Citation: Cs. Cleeland et al., DIMENSIONS OF THE IMPACT OF CANCER PAIN IN A 4 COUNTRY SAMPLE - NEW INFORMATION FROM MULTIDIMENSIONAL-SCALING, Pain, 67(2-3), 1996, pp. 267-273

Authors: SERLIN RC MENDOZA TR NAKAMURA Y EDWARDS KR CLEELAND CS
Citation: Rc. Serlin et al., WHEN IS CANCER PAIN MILD, MODERATE OR SEVERE - GRADING PAIN SEVERITY BY ITS INTERFERENCE WITH FUNCTION, Pain, 61(2), 1995, pp. 277-284

Authors: EDWARDS KR
Citation: Kr. Edwards, FELBAMATE AND TREMOR, Neurology, 45(10), 1995, pp. 1951-1951

Authors: KNAPP MJ KNOPMAN DS SOLOMON PR PENDLEBURY WW DAVIS CS GRACON SI APTER JT LAZARUS CN BAKER KE BARNETT M BAUMEL B EISNER LS CASTELLS B BOLOURI R BENNETT D FORCHETTI C LEVIN A BLASS JP NOLAN KA GAINES ER RELKIN N BORISON RL DIAMOND B CELESIA GG ROSS AP DEXTER J DOODY R LIPSCOMB L KREITER K DUBOFF EA BLOCK P MARSHALL D WESTERGAARD N EARL NL WYNE SV HINMANSMITH E FARLOW M HENDRIE HC CARESS JA FARMER M HARPER JE FERGUSON J FOSTER NL BARBAS NR BLUEMLEIN LA GELB DJ BERENT S GIORDANI B GREENWALD M BERGMAN S ROGER LF GROENENDYK A WOOD M JURKOWSKI C KATZ I DOYLE S SMITH BD KELLNER C BERNSTEIN HJ BACHMAN DL KNOPMAN DS DEINARD S LANGLEY L BRIDGES S MARGOLIN RA BURGER MC WISER SL CRENSHAW C MORRIS JC RUBIN EH COATS MA REYES PF BENTZ C DOYLE LL RYMER MM BETTINGER IE LAUBINGER MP SADOWSKY CH MARTINEZ W ZUNIGA J STONE R WINNER P MATE L LESSARD C SCHNEIDER L PAWLUCZYK S SMITH WT LOSK SN MARAMBE L SOLOMON PR PENDLEBURY WW GROCCIAELLISON ME EDWARDS KR TAYLOR J CALABRESE VP HARKINS SW THEIN SG DEWAR JA WILLIAMS G DRENNAN C TUTTLE P PRINCIPI N FORD EM TYNDALL RJ KELLEY CK
Citation: Mj. Knapp et al., A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE, JAMA, the journal of the American Medical Association, 271(13), 1994, pp. 985-991

Authors: SOLOMON PR GROCCIAELLISON M FLYNN D MIRAK J EDWARDS KR DUNEHEW A STANTON ME
Citation: Pr. Solomon et al., DISRUPTION OF HUMAN EYEBLINK CONDITIONING AFTER CENTRAL CHOLINERGIC BLOCKADE WITH SCOPOLAMINE, Behavioral neuroscience, 107(2), 1993, pp. 271-279

Authors: EDWARDS KR BROSVIC GM DIHOFF RE
Citation: Kr. Edwards et al., INFLUENCES OF ACADEMIC TRAINING AND NONACADEMIC EXPERIENCE ON SUSCEPTIBILITY TO THE HORIZONTAL VERTICAL ILLUSION, Bulletin of the Psychonomic Society, 31(5), 1993, pp. 465-467
Risultati: 1-12 |